Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Abpro Corporation, a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for t... Abpro Corporation, a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers, and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as IE LAB Inc. and changed its name to Abpro Corporation in October 2007. Abpro Corporation was incorporated in 2004 and is headquartered in Woburn, Massachusetts. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0352 | -7.09820528332 | 0.4959 | 0.54 | 0.424 | 82444 | 0.47428454 | CS |
| 4 | -0.2993 | -39.3815789474 | 0.76 | 0.77 | 0.424 | 65247 | 0.52667592 | CS |
| 12 | -1.5393 | -76.965 | 2 | 2.005 | 0.424 | 74651 | 1.08000738 | CS |
| 26 | -4.7393 | -91.1403846154 | 5.2 | 8.8 | 0.424 | 532347 | 1.90780338 | CS |
| 52 | -4.7393 | -91.1403846154 | 5.2 | 8.8 | 0.424 | 532347 | 1.90780338 | CS |
| 156 | -4.7393 | -91.1403846154 | 5.2 | 8.8 | 0.424 | 532347 | 1.90780338 | CS |
| 260 | -4.7393 | -91.1403846154 | 5.2 | 8.8 | 0.424 | 532347 | 1.90780338 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
